Amoxicillin Dosing for Acute Otitis Media
For this 5-year-old, 12 kg patient with acute otitis media and effusion, prescribe high-dose amoxicillin at 80-90 mg/kg/day divided into two daily doses, which equals 480-540 mg twice daily (approximately 1,080 mg total daily dose).
Rationale for High-Dose Amoxicillin
The 2013 AAP guideline on acute otitis media establishes high-dose amoxicillin (80-90 mg/kg/day) as the first-line treatment for most patients 1. This recommendation is based on the need to achieve middle ear fluid concentrations that exceed the minimum inhibitory concentration (MIC) for intermediately resistant Streptococcus pneumoniae and many highly resistant serotypes 1.
The FDA labeling confirms this dosing for severe infections or those in areas with resistant pathogens, specifying 45 mg/kg/day divided every 12 hours for severe ear/nose/throat infections 2. However, current clinical practice and guidelines favor the higher 80-90 mg/kg/day range given evolving resistance patterns.
Specific Dosing Calculation
For this 12 kg child:
- Low end: 80 mg/kg/day × 12 kg = 960 mg/day ÷ 2 doses = 480 mg twice daily
- High end: 90 mg/kg/day × 12 kg = 1,080 mg/day ÷ 2 doses = 540 mg twice daily
Using amoxicillin suspension 250 mg/5 mL:
- 480 mg dose = 9.6 mL (round to 10 mL)
- 540 mg dose = 10.8 mL (round to 11 mL)
Practical prescription: 10-11 mL of 250 mg/5 mL suspension twice daily for 10 days
Twice-Daily vs Three-Times-Daily Dosing
Recent evidence supports twice-daily dosing over three-times-daily administration 3. The 2023 study demonstrated equivalent efficacy between regimens (92% vs 95% favorable outcomes, p=0.25), with twice-daily dosing offering better adherence—only 5.8% of families reported scheduling difficulties compared to 31% with three-times-daily dosing 3. The FDA label supports both 45 mg/kg/day in 2 doses and 40 mg/kg/day in 3 doses 2, but the twice-daily regimen is preferred for practical reasons.
Duration of Treatment
Treat for 10 days 1, 2. The AAP guideline and FDA labeling both recommend a minimum 10-day course for children under 6 years with AOM. Treatment should continue for at least 48-72 hours beyond symptom resolution 2.
Important Clinical Considerations
When to Use Amoxicillin-Clavulanate Instead
Switch to high-dose amoxicillin-clavulanate (90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses) if 1:
- Child received amoxicillin in the previous 30 days
- Concurrent purulent conjunctivitis is present
- Coverage for β-lactamase-producing H. influenzae or M. catarrhalis is specifically desired
Reassessment Timing
Re-examine the patient if symptoms persist or worsen after 48-72 hours of therapy 1, 4. At that point, consider switching to amoxicillin-clavulanate or a second-line agent.
Expected Outcomes
With appropriate amoxicillin therapy, expect 5:
- Treatment failure rate: approximately 5%
- Symptom improvement by day 5: 74%
- Complete resolution by day 5: 47%
- Adverse drug events (primarily diarrhea): 27%
Resistance Considerations
Despite increasing prevalence of β-lactamase-producing bacteria (present in 66% of children in recent studies), treatment failure with amoxicillin remains uncommon and does not significantly differ between children with and without β-lactamase-producing pathogens 5. This supports continued use of amoxicillin as first-line therapy rather than routinely using amoxicillin-clavulanate.